Whether or not a precarcinogen can exert a transplacental action depends on the nature and amount of the appropriate activating enzyme that is present in the fetus. An exception to this statement is provided by cycasin (methylazoxymethanol glucoside), which is converted to its proximate carcinogen, methylazoxymethanol, by enzymes in the microbial flora of the gastrointestinal tract (Laqueur & Spatz 1968 ).
The carcinogenic nitroso compounds include examples of carcinogens, the nitrosamines, that do require metabolic activation, and the nitrosamides, that do not. The nitroso compounds that have been most studied from the standpoint of transplacental carcinogenesis are dimethylnitrosamine and N-methyl-and N-ethylnitrosourea. Dimethylnitrosamine exerts a transplacental carcinogenic action in the rat only when given during the last week of pregnancy (Alexandrov 1968) , and evidence for metabolic activation of the compound was found on the 17th day of pregnancy but not on the 15th day (Magee 1973) . In contrast, N-ethylnitrosourea administered on the 15th and subsequent days of pregnancy in the rat, in doses well below the lethal level, gave rise to tumours of the central and or peripheral nervous system in all of the progeny.
A most interesting feature of the work by Druckrey and his colleagues was the observation that doses of N-ethylnitrosourea at 1/50 of the LD50 to the pregnant rats still induced some tumours of the nervous system in the offspring. Such doses had no readily detectable toxic effects on the treated mother animals (Druckrey 1973a, b) .
The transplacental carcinogenic effects of some chemicals may not be confined to the F1 generation. Work by Tanaka (1973) using N-methyl nitrosourethane, and by Tomatis and his colleagues (Tomatis 1965 , Tomatis & Goodall 1969 with polycyclic hydrocarbons has shown a higher than expected incidence of tumours in the F2 and in some cases the F3 generations of rats derived from mothers treated during pregnancy with the carcinogens. These very interesting findings have obvious implications and warrant further study.
Conclusion
There is no doubt that cancer can be induced transplacentally in human beings and in animals by exposure of pregnant females to some chemical carcinogens. The possible occurrence of such exposure to carcinogens in utero should be considered as an etiological factor in human cancers, particularly those of childhood. , Lanier et al. 1973 appears to be the only direct evidence of transplacental chemical carcinogenesis in man. There are, however, several reasons for thinking that many, and perhaps most, cancers in childhood are initiated before birth.
The epidemiological evidence on the time of initiation of childhood cancer is based on a variety of observations. Association between childhood cancer and obstetric radiography: The evidence for an association between the use of abdominal X-rays during pregnancy and subsequent cancer of the child has been presented in a number of papers (Stewart et al. 1958 , Stewart & Kneale 1970 . The existence and nature of this association have been a matter of controversy for several years. Perhaps the most convincing evidence in favour of a causal relationship is that supplied by recent data from our survey, which shows that there is a marked dose-response relationship (Bithell & Stewart 1975) . This is shown in Table 1 , from which it can be seen that the relative risk increases with the number of films taken.
Association between childhood cancer and virus infections during pregnancy: Reports of an association between viral infections (mainly influenza) during pregnancy and subsequent leukaemia or cancer in the child have appeared in several papers , Leck & Stewart 1972 , Bithell et al. 1973 . Data from our survey are reproduced in Table 2 .
It would appear that the proportion of cases associated with virus infections may be quite small. It is, of course, possible that the association is with medication taken for these diseases rather than with the diseases as such. Congenital and familial factors: It is well known that some types of malignancy are associated with certain groups of congenital defects. Thus leukaemia has been associated with chromosomal abnormalities; this can be illustrated by the connexion between mongolism, leukemia and trisomy 21, and also by the association between acute myelogenous leuk2emia and chromosomal translocation which has been described by Sakurai et al. (1974) . Another example is the association of Wilms's tumour with certain types of growth disturbances, such as hemihypertrophy, maldevelopment of the genitourinary tract and aniridia, though the latter has also recently been associated with partial chromosomal deletion. Both these associations are verified by data from our survey, and other interesting associations do occur. There is also the familial increase in risk. A detailed analysis of such risks (Draper 1974, personal communication) suggests that in families with one affected child, there is a small risk that a further child will be affected by the same disease or another type of tumour. The results of this analysis are summarized in Table 3 , which compares the observed andexpected numbers of cases in families of children with neoplastic disease. The figure for the total number of confirmed cases in the survey (103) is reached after the children suffering from known familial diseases have been eliminated. These figures do not, therefore, include any sibling pairs with a diagnosis of retinoblastoma, von Recklinghausen's disease, or histiocytoses such as Letterer-Siwe disease. It can be inferred from Table 3 that the risk in other sibling-pair families is not quite double the risk in the population as a whole. Thus the risk that a child will develop a neoplasm in this country is about one in 600; where there is a previous sibling with a history of such a disease the risk is approximately one in 300, or 0.3 % in the population at risk. Data from the USA (Miller 1971) show a similar pattern. In such an analysis one cannot exclude the possibility that the familial factor is a consequence of the children sharing a common environment, which could of course be the uterine environment. Alternatively, there may be a direct genetic effect, an increased susceptibility or a reduced immunological response in certain families. (Sanders et al. 1975) , in the hope that these may act as base-line descriptions of the natural history of these tumours for possible future trials of new treatment protocols. It appeared that while the morbidity for boys was in all cases greater than for girls, in neuroblastoma the girls carried a significantly better survival rate than boys, which was not shown in the other two tumours studied. Preliminary studies on brain tumours suggest that here also girls may have a better prognosis.
Suspected therapeutic agents: There is a possible association between childhood cancer and some chronic maternal illnesses, in addition to the viral infections already referred to. If such an association can be proved, it could either result directly from the illness or more probably, it could arise from the prolonged usage of certain drugs during the course of treatment. Data on certain possible associations are available from our survey (Bithell & Draper 1975, unpublished) , but we regard it as premature at this stage to produce these data, since only a preliminary analysis has been carried out.
Currently, we are seeking information on the administration of hormones and ultrasonic tests and on smoking habits during pregnancy. We are also investigating the occurrence of breastfeeding and the usage of contraceptive drugs before conception of the survey child.
Finally, it would be a fascinating project to apply epidemiological methods to the whole question of the administration of immunosuppressive drugs during pregnancy and immunological deficiency diseases at birth. The work of Cote (1974) suggests that the use of immunosuppressive drugs may have a transplacental effect, and the subsequent children may have increased susceptibility not only to infections but also to lymphomas.
